kawasaki
syndrom
ks
mostli
diagnos
infant
children
without
possibl
identifi
primum
moven
remain
larg
mysteri
almost
clinic
set
diagnost
assess
ks
deriv
combin
prolong
fever
last
day
least
standard
clinic
sign
bilater
conjunctiv
inject
oropharyng
polymorph
skin
rash
cervic
lymphadenopathi
peripher
chang
involv
extrem
perineum
lack
specif
diagnost
test
contribut
delay
ks
diagnosi
even
popul
condit
wide
recogn
time
recognit
ks
essenti
maxim
prevent
overt
coronari
arteri
damag
treatment
beyond
day
onset
often
associ
wors
outcom
increas
incid
coronari
abnorm
specif
ration
intervent
could
develop
etiopathogenesi
ks
fulli
understood
mani
immunolog
abnorm
ks
suggest
infecti
trigger
role
coexist
infect
ks
onset
adequ
investig
herebi
report
two
healthi
patient
clinic
pictur
relat
ks
reveal
concurr
infect
coxsacki
viru
type
healthi
male
child
caucasian
origin
hospit
fever
maxim
peak
abdomin
pain
began
day
cardiac
respiratori
abdomin
examin
normal
admiss
tonsillopharyng
cervic
lymph
node
enlarg
seen
laboratori
find
reveal
hemoglobin
gdl
white
blood
cell
count
neutrophil
lymphocyt
platelet
count
creactiv
protein
mgl
crp
nv
aspart
transaminas
iul
ast
nv
alanin
transaminas
iul
alt
nv
total
bilirubin
mgdl
nv
conjug
bilirubin
mgdl
nv
transpeptidas
iul
nv
alkalin
phosphatas
iul
nv
lactat
dehydrogenas
iul
nv
laboratori
test
includ
clot
test
normal
follow
day
patient
remain
feverish
present
bilater
nonpurul
conjunctiv
hyperemia
day
hospit
diffus
erythemat
maculopapular
rash
note
associ
mild
edema
hand
glossiti
red
crack
lip
fever
durat
persist
hypertransaminasemia
blood
throat
stool
cultur
steril
atyp
ks
due
liver
involv
diagnos
patient
treat
intraven
immunoglobulin
ivig
gkg
infus
along
oral
acetylsalicyl
acid
mgkgday
time
echocardiographi
show
hyperechogen
aspect
coronari
arteri
mild
mitral
insuffici
abdomin
ultrasound
show
normal
dimens
structur
liver
normal
gallbladd
without
sign
lithiasi
clinic
improv
rapidli
obtain
fever
subsid
within
h
hypertransaminasemia
regress
day
hospit
ast
iul
alt
iul
cutan
desquam
finger
toe
becam
evid
week
creactiv
protein
becam
normal
acetylsalicyl
acid
shift
singl
dose
mgkgday
serolog
test
viru
hepat
b
c
reaction
neg
indirect
solidphas
micropl
enzymelink
immunosorb
assay
elisa
inst
virionserion
gmbh
germani
detect
igg
igm
iga
coxsacki
virus
method
rapid
enteroviru
molecular
diagnosi
avail
clinic
cours
unev
young
boy
discharg
day
echocardiographi
complet
normal
elisa
confirm
igg
iga
coxsacki
virus
complement
fixat
test
cft
group
b
coxsacki
virus
inst
virion
ltd
ruschlikon
switzerland
perform
week
diagnosi
show
antibodi
acetylsalicyl
acid
maintain
period
month
time
cardiolog
assess
within
normal
limit
healthi
femal
child
born
philippin
hospit
consequ
histori
fever
peak
poor
feed
itchi
erythemat
rash
resist
cetirizin
slight
edema
feet
physic
examin
reveal
exud
pharyng
micropapular
rash
becam
diffus
bodi
day
suggest
infecti
natur
diseas
laboratori
test
show
hemoglobin
gdl
white
blood
cell
count
neutrophil
lymphocyt
platelet
count
crp
mgl
normal
serum
transaminas
level
clot
test
echocardiographi
perform
day
fever
neg
attempt
cultur
virus
throat
swab
cerebrospin
fluid
stool
unsuccess
day
intermitt
fever
child
present
conjunctiv
hyperemia
day
echocardiographi
reveal
diffus
hyperechogen
right
coronari
arteri
normal
left
coronari
arteri
fig
confirm
clinic
suspicion
ks
treatment
ivig
gkg
singl
infus
oral
acetylsalicyl
acid
mgkgday
start
fever
disappear
follow
day
serolog
test
viru
cytomegaloviru
toxoplasma
gondii
herp
viru
rubella
viru
adenoviru
parvoviru
rickettsi
diseas
neg
igm
iga
coxsacki
virus
found
elisa
method
enterovir
rna
recognit
unavail
week
heart
ultrasound
assess
complet
normal
elisa
reveal
igg
coxsacki
virus
mild
peel
ii
finger
right
hand
also
note
clinic
cours
child
regular
discharg
overal
period
day
acetylsalicyl
acid
maintain
antiplatelet
dosag
mgkgday
period
week
patient
recal
week
later
convalesc
phase
serum
sampl
cft
reveal
antibodi
among
factor
make
ks
difficult
diseas
studi
etiolog
point
view
strict
predilect
smaller
age
ethnic
group
problemat
collect
biopsi
specimen
long
debat
whether
etiolog
agent
ks
might
bacteri
viral
origin
fact
ks
clinic
cours
appear
quit
similar
scarlet
fever
toxic
shock
syndrom
caus
bacteri
exotoxin
treatabl
proper
antibiot
also
viral
ill
adenovir
infect
measl
infecti
mononucleosi
search
singl
microbiolog
caus
ks
disappoint
mani
hypothet
etiolog
factor
report
tabl
role
superantigen
group
streptococcu
staphylococcu
aureu
promot
tcell
activ
lead
extens
immunolog
reaction
genet
suscept
individu
controversi
epidemiolog
characterist
ks
conflict
possibl
newli
emerg
virus
avian
influenza
retrovirus
might
caus
ks
esper
et
al
report
associ
new
human
coronaviru
ks
detect
viru
revers
transcriptionpolymeras
chain
reaction
respiratori
sampl
infant
ks
though
associ
disavow
studi
catalanopon
et
al
report
infant
incomplet
ks
coronari
aneurysm
primari
cytomegaloviru
infect
intraven
ganciclovir
improv
clinic
echocardiograph
abnorm
ivig
ineffect
bensel
et
al
evalu
retrospect
rate
concurr
infect
time
ks
diagnosi
cohort
children
period
found
variou
infect
tonsil
posit
throat
cultur
group
streptococcu
viral
ill
confirm
evid
serolog
posit
igm
antibodi
chest
radiographproven
pneumonia
urinari
tract
infect
gastroenter
andor
sepsi
present
patient
though
infect
influenc
respons
ivig
similarli
appar
uninfect
patient
coxsacki
b
virus
identifi
major
caus
human
viral
myocard
sinc
also
thought
play
signific
role
develop
dilat
cardiomyopathi
particular
one
coxsacki
b
serotyp
known
caus
asept
mening
enceph
myocard
gener
infect
infant
although
recogn
cardiotox
mechan
lead
viral
cardiovirul
still
unravel
preval
coxsacki
viru
infect
develop
world
unknown
outbreak
mani
countri
rare
even
newborn
role
enterovirus
ks
defin
best
knowledg
associ
coxsacki
b
virus
previous
report
report
describ
two
ks
case
patient
present
diagnost
sign
combin
sign
liver
diseas
develop
hyperechogen
coronari
arteri
patient
present
criteria
present
transient
hyperechogen
right
coronari
arteri
though
cardiolog
sequel
observ
one
diagnosi
coxsacki
viru
infect
ks
patient
base
elisa
past
decad
trend
replac
cft
direct
sensit
rapid
techniqu
elisa
even
cft
remain
extrem
use
definit
viru
identif
type
need
patient
fact
cft
consent
demonstr
signific
antibodi
serum
titer
convalesc
phase
might
display
trigger
role
ks
develop
two
previous
healthi
unrel
children
investig
need
explor
potenti
relationship
enterovirus
ks
establish
infect
caus
specif
serotyp
coxsacki
viru
mere
concurr
phenomenon
clarifi
etiolog
ks
might
disclos
interact
involv
develop
vascular
diseas
atherosclerosi
though
lack
singl
unifi
etiolog
agent
despit
signific
research
effort
suggest
ks
follow
exposur
varieti
infecti
agent
stereotyp
immun
respons
might
occur
genet
suscept
host
